rs74357545

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_016953.4(PDE11A):​c.2632A>G​(p.Met878Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 1,589,640 control chromosomes in the GnomAD database, including 139 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0068 ( 7 hom., cov: 32)
Exomes 𝑓: 0.011 ( 132 hom. )

Consequence

PDE11A
NM_016953.4 missense

Scores

3
15

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.45

Publications

23 publications found
Variant links:
Genes affected
PDE11A (HGNC:8773): (phosphodiesterase 11A) The 3',5'-cyclic nucleotides cAMP and cGMP function as second messengers in a wide variety of signal transduction pathways. 3',5'-cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cGMP to the corresponding 5'-monophosphates and provide a mechanism to downregulate cAMP and cGMP signaling. This gene encodes a member of the PDE protein superfamily. Mutations in this gene are a cause of Cushing disease and adrenocortical hyperplasia. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
PDE11A-AS1 (HGNC:40433): (PDE11A antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.020577222).
BP6
Variant 2-177663880-T-C is Benign according to our data. Variant chr2-177663880-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 377121.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00677 (1032/152328) while in subpopulation NFE AF = 0.0119 (810/68038). AF 95% confidence interval is 0.0112. There are 7 homozygotes in GnomAd4. There are 443 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1032 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PDE11ANM_016953.4 linkc.2632A>G p.Met878Val missense_variant Exon 19 of 20 ENST00000286063.11 NP_058649.3 Q9HCR9-1
PDE11ANM_001077197.2 linkc.1882A>G p.Met628Val missense_variant Exon 20 of 21 NP_001070665.1 Q9HCR9-2
PDE11ANM_001077358.2 linkc.1558A>G p.Met520Val missense_variant Exon 18 of 19 NP_001070826.1 Q9HCR9-3
PDE11ANM_001077196.2 linkc.1300A>G p.Met434Val missense_variant Exon 16 of 17 NP_001070664.1 Q9HCR9-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PDE11AENST00000286063.11 linkc.2632A>G p.Met878Val missense_variant Exon 19 of 20 1 NM_016953.4 ENSP00000286063.5 Q9HCR9-1

Frequencies

GnomAD3 genomes
AF:
0.00678
AC:
1032
AN:
152210
Hom.:
7
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00236
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00360
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.00433
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0119
Gnomad OTH
AF:
0.00670
GnomAD2 exomes
AF:
0.00655
AC:
1645
AN:
251106
AF XY:
0.00664
show subpopulations
Gnomad AFR exome
AF:
0.00228
Gnomad AMR exome
AF:
0.00544
Gnomad ASJ exome
AF:
0.00189
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00314
Gnomad NFE exome
AF:
0.0109
Gnomad OTH exome
AF:
0.00800
GnomAD4 exome
AF:
0.0110
AC:
15750
AN:
1437312
Hom.:
132
Cov.:
27
AF XY:
0.0106
AC XY:
7618
AN XY:
716870
show subpopulations
African (AFR)
AF:
0.00206
AC:
68
AN:
32982
American (AMR)
AF:
0.00551
AC:
246
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
0.00242
AC:
63
AN:
25994
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39576
South Asian (SAS)
AF:
0.00170
AC:
146
AN:
85772
European-Finnish (FIN)
AF:
0.00320
AC:
171
AN:
53402
Middle Eastern (MID)
AF:
0.000700
AC:
4
AN:
5718
European-Non Finnish (NFE)
AF:
0.0133
AC:
14438
AN:
1089568
Other (OTH)
AF:
0.0103
AC:
614
AN:
59616
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
663
1326
1989
2652
3315
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
554
1108
1662
2216
2770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00677
AC:
1032
AN:
152328
Hom.:
7
Cov.:
32
AF XY:
0.00595
AC XY:
443
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00236
AC:
98
AN:
41562
American (AMR)
AF:
0.00359
AC:
55
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00124
AC:
6
AN:
4820
European-Finnish (FIN)
AF:
0.00433
AC:
46
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0119
AC:
810
AN:
68038
Other (OTH)
AF:
0.00663
AC:
14
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
52
104
156
208
260
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00916
Hom.:
21
Bravo
AF:
0.00693
TwinsUK
AF:
0.0162
AC:
60
ALSPAC
AF:
0.0112
AC:
43
ESP6500AA
AF:
0.00272
AC:
12
ESP6500EA
AF:
0.0133
AC:
114
ExAC
AF:
0.00649
AC:
788
Asia WGS
AF:
0.00173
AC:
6
AN:
3478
EpiCase
AF:
0.0119
EpiControl
AF:
0.0111

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 30, 2016
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.34
CADD
Benign
17
DANN
Benign
0.97
DEOGEN2
Benign
0.16
T;.;.;.
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.10
FATHMM_MKL
Uncertain
0.82
D
LIST_S2
Uncertain
0.92
D;D;D;D
MetaRNN
Benign
0.021
T;T;T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
0.53
N;.;.;.
PhyloP100
1.4
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.3
N;N;N;N
REVEL
Benign
0.16
Sift
Uncertain
0.028
D;D;D;D
Sift4G
Benign
0.071
T;T;T;T
Polyphen
0.027
B;.;.;B
Vest4
0.64
MVP
0.68
MPC
0.19
ClinPred
0.0061
T
GERP RS
3.7
Varity_R
0.18
gMVP
0.39
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs74357545; hg19: chr2-178528608; API